Ritter Pharmaceuticals Company
.png)
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
Estimated Revenue:
Less than $1M
Funding Status:
IPO
Industry:
Biotechnology, Clinical Trials, Health Diagnostics, Medical, PharmTech, Pharmaceutical, Robotics
Last Funding Date:
2015
Number Of Exists:
N/A
Technology:
Anti-infective Drugs
Founded Date:
2004-01-01
Investor Type:
N/A
Headquarters:
Greater Los Angeles Area, West Coast, Western US
Total Funding:
25730038
Last Funding Type:
Post-IPO Equity
Employee Number:
11-50
Investment Stage:
N/A